Erratum. Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell–Derived β-Cells Harboring a Partially Functional WFS1 Variant. Diabetes 2025;74:1273–1288



In the article cited above, TG was incorrectly introduced as transforming secretory granules in the main text. The correct term is thapsigargin.



Source link